Article Information
PubMed
Print ISSN
Online ISSN
History
- Received July 4, 2020
- Accepted November 3, 2020
- Published online January 19, 2021.
Article Versions
- Earlier version (November 6, 2020 - 11:09).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2021 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Radhika Joshi1,
- Omar Hamed1,
- Dong Yan1,2,
- Aubrey N. Michi,
- Mahmoud M. Mostafa,
- Shahina Wiehler,
- Robert Newton, and
- Mark A. Giembycz
- Department of Physiology and Pharmacology, Airways Inflammation Research Group, Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
- Address correspondence to:
Dr. Mark A. Giembycz, Department of Physiology and Pharmacology, Airways Inflammation Research Group, Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, 3820 Hospital Dr. N.W., Calgary, AB, Canada T2N 4N1. E-mail: giembycz{at}ucalgary.ca
Statistics from Altmetric.com
Article usage
In this issue
Genomic Effects of an EP4-Receptor Agonist in Human Airway Epithelia
